NEXGEL, Inc.
General ticker "NXGL" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $19.9M (TTM average)
NEXGEL, Inc. does not follow the US Stock Market performance with the rate: -16.3%.
Estimated limits based on current volatility of 3.0%: low 1.63$, high 1.73$
Factors to consider:
- Total employees count: 6 as of 2019
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Market acceptance, Supply chain disruptions, Market competition, Regulatory and compliance, Product liability
- Current price 39.4% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.03$, 5.96$]
- 2025-12-31 to 2026-12-31 estimated range: [2.66$, 5.30$]
Financial Metrics affecting the NXGL estimates:
- Positive: with PPE of -9.8 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -12.88 <= 0.04
- Positive: 42.53 < Shareholder equity ratio, % of 52.40 <= 64.17
- Negative: Industry operating cash flow per share per price (median), % of 1.00 <= 5.42
- Positive: -9.48 < Industry operating profit margin (median), % of -6.69
- Positive: Inventory ratio change, % of -8.79 <= -0.76
- Positive: Interest expense per share per price, % of 0.27 <= 0.74
Short-term NXGL quotes
Long-term NXGL plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2.05MM | $4.09MM | $8.69MM |
| Operating Expenses | $5.40MM | $7.57MM | $12.24MM |
| Operating Income | $-3.35MM | $-3.48MM | $-3.55MM |
| Non-Operating Income | $-1.40MM | $0.29MM | $0.09MM |
| Interest Expense | $1.34MM | $0.01MM | $0.08MM |
| R&D Expense | $0.37MM | $0.10MM | $0.08MM |
| Income(Loss) | $-4.75MM | $-3.19MM | $-3.46MM |
| Profit(Loss)* | $-4.75MM | $-3.16MM | $-3.28MM |
| Stockholders Equity | $7.64MM | $4.70MM | $5.75MM |
| Inventory | $0.50MM | $1.32MM | $1.75MM |
| Assets | $10.36MM | $9.96MM | $10.98MM |
| Operating Cash Flow | $-2.99MM | $-3.24MM | $-3.87MM |
| Capital expenditure | $0.10MM | $0.70MM | $0.44MM |
| Investing Cash Flow | $-5.59MM | $4.46MM | $-0.78MM |
| Financing Cash Flow | $-3.66MM | $0.38MM | $3.75MM |
| Earnings Per Share** | $-0.85 | $-0.56 | $-0.50 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.